Background

Content Library

Filter
Type
Topic
Product
  • Publication
  • Sep 8, 2015
Activation of the C-H bond of Methane by Intermediate Q of Methane Monoozygenase: A Theoretical Study
Gherman, et al. J. Am. Chem. Soc., 2001, 123, 3836-3837
  • Publication
  • Sep 8, 2015
Large Scale Ab Initio Quantum Chemical Calculations on Biological Systems
Friesner, et al. Accounts of Chemical Research, 2001, 34, 351-358
  • Publication
  • Sep 8, 2015
Peroxide-dependent formation of a covalent link between Trp51 and the heme in cytochrome c peroxidase
Pipirou Z., et al. Biochemistry, 2009, 48, 3593-3599
  • Publication
  • Sep 8, 2015
Remarkable Stereospecific Conjugate Additions to the Hsp90 Inhibitor Celastrol
Klai’, et al. J. Am. Chem. Soc., 2011, 133, 19634-19637
  • Publication
  • Sep 8, 2015
On the Rational Design of Zeolite Clusters
Migues, et al. ACS Catal., 2015, 5, 2859-2865
  • Publication
  • Sep 8, 2015
Pseudospectral Time-Dependent Density Functional Theory
Ko, et al. J. Chem. Phys., 2008, 128, 104103-104111
  • Publication
  • Sep 8, 2015
2,6-Disubstituted N-Arylsulfonyl Piperidines as Gamma-Secretase Inhibitors
Pissarnitski, et al. Bioorganic & Medicinal Chemistry Letters, 2007, 17, 57-62
  • Publication
  • Sep 8, 2015
Synthesis and conformational analysis of novel trimeric maleimide cross-linking reagents
Szczepanska, et al. J. Org. Chem., 2007, 72, 6776-6785
  • Publication
  • Sep 8, 2015
Redox-Modulated Recognition of Tetrazines Using Thioureas
Jordan, et al. Org. Lett., 2007, 9, 2835-2838
dark theme background

Latest insights from Extrapolations blog

With FEP+, “The Experiment is the Limit.”
With FEP+, “The Experiment is the Limit.”

Over the past century, small molecule drugs have represented the dominant modality in drug research, enabling medical breakthroughs that have saved countless lives.

Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods (FEP)
Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods

The complexity and size of drug candidates has grown in recent years as scientists pursue novel targets once considered undruggable.

Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In Blog
Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In

We recently sat down with Edward Miller, Senior Director of Protein Structure Modeling at Schrödinger, to discuss his experience using AlphaFold models for SBDD.

Training & Resources

Online certification courses

Level up your skill set with hands-on, online molecular modeling courses. These self-paced courses cover a range of scientific topics and include access to Schrödinger software and support.

Free learning resources

Learn how to deploy the technology and best practices of Schrödinger software for your project success. Find training resources, tutorials, quick start guides, videos, and more.